
Journal of Medicinal Chemistry p. 1295 - 1299 (1984)
Update date:2022-08-05
Topics:
Strazzolini, Paolo
Malabarba, Adriano
Ferrari, Pietro
Grandi, Maria
Cavalleri, Bruno
L-Alanosine <3-(hydroxynitrosoamino)-L-alanine> is an antitumor antibiotic that at the present is undergoing phase II clinical trials.Its mode of action as well as its metabolism has been extensively studied, and the metabolite N-<(5-amino-1-β-D-ribofuran
View MoreContact:86-571-86737118-8689
Address:No.69, 12 Street, HEDA, Hangzhou, Zhejiang, China
Yueyang Hudex Pharmaceuticals Ltd.
Contact:0730-8748800
Address:Wujiang Bridge,Yueyang Economy & Technology Development Zone
Contact:+86-571-86217390
Address:No.567 Dengcai Street,Sandun,Westlake District,Hangzhou310030,Zhejiang,China.
Shandong Bolode Bio-Technology Co., LTD
Contact:+86-0531-58966870
Address:136 Jingyi Road,Huaiyin District,Jinan,Shandong,China
ChangZhou Mascotchem. Co.,Ltd.
website:http://www.mascotchem.com
Contact:86-519-85010339
Address:B-802,XingBei Building,391#,Tongjiang Middle Road New District,Changzhou,JS,China
Doi:10.1021/op060125+
(2006)Doi:10.1039/b607710b
(2006)Doi:10.1016/j.jorganchem.2006.05.041
(2006)Doi:10.1016/S0040-4020(01)82384-X
(1993)Doi:10.1016/0022-328X(84)80108-4
(1984)Doi:10.1021/jo00193a008
(1984)